Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 61Recruiting 17Active not recruiting 10Unknown 7Not yet recruiting 7Withdrawn 3Terminated 2Enrolling by invitation 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Pancreatic Neoplasms 1Muscular Diseases 1Motor Activity 1Gastric Adenocarcinoma 1Cachexia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Resistance Training × Clear all
NCT05056805 2024-10-26

An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study

M.D. Anderson Cancer Center

Phase NA Withdrawn
Gastrointestinal

Gastric Adenocarcinoma

NCT04449809 2021-06-21

EXERT-BC

Duke University

Phase NA Withdrawn
Breast

Breast Neoplasms, Motor Activity

NCT01395563 2015-03-13

STOPC

German Cancer Research Center

Phase NA Withdrawn
Gastrointestinal

Cachexia, Muscular Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡